PRIME: priority medicines
PRIME: priority medicines
PRIME: priority medicines
List of medicines currently in PRIME scheme
Human medicines European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), telmisartan, Date of authorisation: 16/12/1998, Revision: 32, Status: Withdrawn
How to submit information on authorised and investigational medicines
Reporting requirements for marketing-authorisation holders
Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 7, Status: Authorised
PRAC rules of procedure
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
Concept paper on the guideline revision on good pharmacogenomic practice
Agenda - Management Board meeting: 30 September 2026